Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-030632
Filing Date
2025-10-07
Accepted
2025-10-07 16:06:59
Documents
2
Period of Report
2025-10-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 2990
2 EXHIBIT 24 donofriopoa.htm EX-24 10610
  Complete submission text file 0001437749-25-030632.txt   15349
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Issuer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AYTU BIOSCIENCE, INC. 373 INVERNESS PARKWAY, SUITE 200 ENGLEWOOD CO 80112
Business Address
Donofrio John Jr. (Reporting) CIK: 0001679841 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38247 | Film No.: 251379898